Cite
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy
MLA
Arora S, et al. “Synthesis, Characterization, and Evaluation of Poly (D,L-Lactide-Co-Glycolide)-Based Nanoformulation of MiRNA-150: Potential Implications for Pancreatic Cancer Therapy.” International Journal of Nanomedicine, vol. 2014, no. Issue 1, June 2014, pp. 2933–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2d45006ddfa4d9c96303372e58c1fa2&authtype=sso&custid=ns315887.
APA
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, & Singh AP. (2014). Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine, 2014(Issue 1), 2933–2942.
Chicago
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, and Singh AP. 2014. “Synthesis, Characterization, and Evaluation of Poly (D,L-Lactide-Co-Glycolide)-Based Nanoformulation of MiRNA-150: Potential Implications for Pancreatic Cancer Therapy.” International Journal of Nanomedicine 2014 (Issue 1): 2933–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2d45006ddfa4d9c96303372e58c1fa2&authtype=sso&custid=ns315887.